Alpa Laboratories Ltd.
BSE: 532878 | Sector: Health care |
NSE: ALPA | ISIN Code: INE385I01010 |
BSE 00:00 | 08 Aug | 65.10 |
-0.75 (-1.14%) |
OPEN
64.95 |
HIGH
66.50 |
LOW
64.65 |
NSE 00:00 | 08 Aug | 65.15 |
(%) |
OPEN
67.70 |
HIGH
67.70 |
LOW
64.35 |
OPEN | 64.95 |
PREVIOUS CLOSE | 65.85 |
VOLUME | 12840 |
52-Week high | 108.95 |
52-Week low | 48.00 |
P/E | 9.70 |
Mkt Cap.(Rs cr) | 137 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Alpa Laboratories Ltd.
Mr. Purushottam R. Patel Mr. M.S. Chawla and Mr. Pravin C. Shah partners of M/s Alpa Laboratories which was formed in the year 1967 incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18 1988 for manufacture of pharmaceutical formulations. In the year 1998 Alpa Laboratories Private Limited was converted into a public limited company with effect from Sep...> More
Alpa Laboratories Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
137 | |
EPS - TTM | (![]() |
[*S] | 6.71 |
P/E Ratio | (X) | [*S] | 9.70 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | - | |
Latest Dividend Date | - | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 62.57 |
P/B Ratio | (![]() |
[*S] | 1.04 |
Announcement
-
Statement Of Investor Complaints For The Quarter Ended June 2022
-
Alpa Laboratories Limited - Disclosure under SEBI Takeover Regulations
-
Disclosure Under Regulations 10 (6) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulat
-
Disclosure Under Regulations 29 (2) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulat
Alpa Laboratories Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 25.16 | 24.99 | 0.68 |
Other Income | 1.64 | 0.66 | 148.48 |
Total Income | 26.8 | 25.65 | 4.48 |
Total Expenses | 24.27 | 23.77 | 2.1 |
Operating Profit | 2.53 | 1.88 | 34.57 |
Net Profit | -3.49 | -2.02 | -72.77 |
Equity Capital | 21.04 | 21.04 | - |
Alpa Laboratories Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Medico Remedies | 91.95 | 2.00 | 152.64 |
Vikram Thermo | 48.05 | 2.67 | 150.68 |
Samrat Pharma | 453.15 | 4.64 | 140.02 |
Alpa Laboratorie | 65.10 | -1.14 | 136.97 |
Gennex Lab. | 6.72 | 1.36 | 127.55 |
Natural Caps. PP | 399.90 | -0.77 | 124.77 |
Everest Organics | 144.20 | 3.07 | 115.36 |
Alpa Laboratories Ltd - SHAREHOLDING PATTERN
|
|
Alpa Laboratories Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -4.82% | -4.96% | 1.27% | 1.07% |
1 Month | 5.25% | 6.11% | 8.02% | 8.04% |
3 Month | -12.62% | -12.43% | 7.33% | 6.79% |
6 Month | -22.64% | -22.21% | 1.81% | 1.50% |
1 Year | 23.30% | 23.16% | 8.43% | 7.93% |
3 Year | 332.56% | 327.21% | 57.67% | 58.85% |
Alpa Laboratories Ltd - STOCK STRENGTH
Today's Low/High | 64.65 | 66.50 | |
Week Low/High | 63.30 | 72.00 | |
Month Low/High | 59.20 | 72.00 | |
YEAR Low/High | 48.00 | 109.00 | |
All TIME Low/High | 5.50 | 109.00 |
Quick Links for Alpa Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices